Neurodegenerative Diseases

Karger Publishers

Evaluation status available after sign-in

About the journal

Neurodegenerative Diseases is a journal published by Karger Publishers in Switzerland. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Karger Publishers
ISSN
1660-2854 · 1660-2862
Country
Switzerland
Access
Not open access / not declared

Index listings

  • MEDLINE · 2004-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
136 days received→accepted — computed from PubMed (n=47)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1299

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

81

i10-index

698

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
63%
ORCID iDs in current deposits
41%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Neuro-degenerative diseases
Source type
journal
NLM unique ID (PubMed)
101189034
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Alzheimer's disease research and treatments
  • Alzheimer's disease research and treatments
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Parkinson's Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
Show all subjects (75)
  • Amyotrophic Lateral Sclerosis Research
  • Amyotrophic Lateral Sclerosis Research
  • Amyotrophic Lateral Sclerosis Research
  • Dementia and Cognitive Impairment Research
  • Dementia and Cognitive Impairment Research
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Genetic Neurodegenerative Diseases
  • Genetic Neurodegenerative Diseases
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Neurological disorders and treatments
  • Neurological disorders and treatments
  • Neurological disorders and treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Genetic Neurodegenerative Diseases
  • Nuclear Receptors and Signaling
  • Neuroscience and Neuropharmacology Research
  • Neuroscience and Neuropharmacology Research
  • Neuroscience and Neuropharmacology Research
  • Mitochondrial Function and Pathology
  • Neurological diseases and metabolism
  • Mitochondrial Function and Pathology
  • Neurological diseases and metabolism
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Hereditary Neurological Disorders
  • Neurogenetic and Muscular Disorders Research
  • Neurogenetic and Muscular Disorders Research
  • Nuclear Receptors and Signaling
  • Legal Cases and Commentary
  • Cholinesterase and Neurodegenerative Diseases
  • Nuclear Receptors and Signaling
  • Legal Cases and Commentary
  • Prion Diseases and Protein Misfolding
  • Prion Diseases and Protein Misfolding
  • Physics and Engineering Research Articles
  • Physics and Engineering Research Articles
  • Neurological Disease Mechanisms and Treatments
  • Neurogenesis and neuroplasticity mechanisms
  • Neurogenesis and neuroplasticity mechanisms
  • Nerve injury and regeneration
  • Nerve injury and regeneration
  • Neurological diseases and metabolism
  • Neurogenesis and neuroplasticity mechanisms
  • Neurological Disease Mechanisms and Treatments
  • Neurological Disease Mechanisms and Treatments
  • Functional Brain Connectivity Studies
  • Functional Brain Connectivity Studies
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Genetics and Neurodevelopmental Disorders
  • Neurogenetic and Muscular Disorders Research
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Tryptophan and brain disorders
  • Tryptophan and brain disorders
  • Prion Diseases and Protein Misfolding
  • Multiple Sclerosis Research Studies
  • Cerebrospinal fluid and hydrocephalus
  • Medical Imaging Techniques and Applications
  • Genetic Associations and Epidemiology
  • Balance, Gait, and Falls Prevention
  • Lysosomal Storage Disorders Research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Peripheral Neuropathies and Disorders

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: